These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8193284)

  • 21. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
    Ariga R; Zarif A; Korasick J; Reddy V; Siziopikou K; Gattuso P
    Breast J; 2005; 11(4):278-80. PubMed ID: 15982396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis.
    Chen SL; Hoehne FM; Giuliano AE
    Ann Surg Oncol; 2007 Dec; 14(12):3378-84. PubMed ID: 17899293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer.
    Neri A; Marrelli D; Pedrazzani C; Caruso S; De Stefano A; Mariani F; Megha T; De Marco G; Corso G; Pinto E; Roviello F
    Eur J Surg Oncol; 2008 Dec; 34(12):1299-303. PubMed ID: 18164172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathology and behavior of small breast carcinomas.
    Meyer JS; Fahrner M; Daniel FC
    Semin Diagn Pathol; 1999 Aug; 16(3):257-68. PubMed ID: 10490202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
    Masiuk M
    Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
    Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
    J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E2F-1: a proliferative marker of breast neoplasia.
    Zhang SY; Liu SC; Al-Saleem LF; Holloran D; Babb J; Guo X; Klein-Szanto AJ
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):395-401. PubMed ID: 10794484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
    Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
    Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer.
    Nakamura Y; Yasuoka H; Tsujimoto M; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Breast Cancer Res Treat; 2005 May; 91(2):125-32. PubMed ID: 15868440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Growth rate and natural history of breast cancer].
    Tubiana M; Chauvel P; Renaud A; Malaise EP
    Bull Cancer; 1975; 62(4):341-58. PubMed ID: 1212522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymidine labeling index: prognostic role in breast cancer.
    Bilir A; Ozmen V; Kecer M; Eralp Y; Cabioglu N; Ahishali B; Camlica H; Aydiner A
    Am J Clin Oncol; 2004 Aug; 27(4):400-6. PubMed ID: 15289735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Complex cytomorphological determination of the degree of anaplasia of breast cancer cells].
    Ganina KP; Ishchenko VE
    Arkh Patol; 1986; 48(2):24-9. PubMed ID: 3707386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic and predictive value of thymidine labelling index in breast cancer.
    Amadori D; Silvestrini R
    Breast Cancer Res Treat; 1998; 51(3):267-81. PubMed ID: 10068084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Labelling index in breast cancer and in upper respiratory and digestive tract cancer (author's transl)].
    Gioanni J; Farges MF; Asin C; Lalanne CM
    Bull Cancer; 1979; 66(5):479-84. PubMed ID: 554672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinoma.
    Alama A; Merlo F; Chiara S; Muttini MP; Guido T; Nicolò G; Conte PF; Ragni N
    Eur J Cancer; 1992; 28A(6-7):1079-80. PubMed ID: 1627379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The errors of thymidine labelling in breast cancer.
    Smallwood JA; Cooper A; Taylor I
    Clin Oncol; 1983 Dec; 9(4):331-5. PubMed ID: 6661855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Proliferative activity of tumor cells as a prognostic factor in breast cancer].
    Guliak NS; Sergeeva NS; Slavnova EN; Chissov VI; Babarina AV; Demidov VP; Pak DD; Dzhubalieva SK
    Biull Eksp Biol Med; 1995 Aug; 120(8):215-7. PubMed ID: 7579291
    [No Abstract]   [Full Text] [Related]  

  • 39. 3H-thymidine labelling index (TLI) as a marker of tumour growth heterogeneity: evaluation in human solid carcinomas.
    Becciolini A; Balzi M; Barbarisi M; Faraoni P; Biggeri A; Potten CS
    Cell Prolif; 1997; 30(3-4):117-26. PubMed ID: 9375024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term prognostic significance of thymidine labelling index in primary breast cancer.
    Cooke TG; Stanton PD; Winstanley J; Murray GD; Croton R; Holt S; George WD
    Eur J Cancer; 1992; 28(2-3):424-6. PubMed ID: 1591056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.